LCM
UTHR icon

Landscape Capital Management’s United Therapeutics UTHR Stock Holding History

Landscape Capital Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-837
Closed -$496K – 922
2026
Q1 		$496K Buy
+837
New +$417K 0.03% 506
2024
Q2 		– Sell
-1,501
Closed -$345K – 901
2024
Q1 		$345K Buy
+1,501
New +$339K 0.03% 512
2023
Q1 		– Sell
-1,047
Closed -$291K – 789
2022
Q4 		$291K Buy
+1,047
New +$264K 0.04% 410
2016
Q1 		– Sell
-3,100
Closed -$485K – 820
2015
Q4 		$485K Buy
+3,100
New +$451K 0.06% 499
2015
Q2 		– Sell
-5,000
Closed -$862K – 774
2015
Q1 		$862K Buy
+5,000
New +$762K 0.23% 95

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Landscape Capital Management's UTHR Position: Q2 2026 in Review

Landscape Capital Management sold out of United Therapeutics (UTHR) in Q2 2026, closing a stake of 837 shares — an estimated $496K sold.

Landscape Capital Management first reported a position in UTHR in Q1 2015 and held it in 5 quarters. The position peaked at $862K in Q1 2015. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Landscape Capital Management reported no remaining United Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Landscape Capital Management sold 837 United Therapeutics shares in Q2 2026, an estimated $496K.
  • Landscape Capital Management first reported a position in United Therapeutics in Q1 2015 and held it in 5 quarters.
  • Landscape Capital Management's United Therapeutics position peaked at $862K in Q1 2015.
  • 882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Landscape Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.